$1.390
-0.085 (-6.08%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
NMRA Prediction & Forecast by Similar Chart Analysis
Alphio's NMRA stock price prediction model matches the current Neumora Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.40 (+1.01%). The 1-week path is $1.53 (+10.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Neumora Therapeutics Inc Stock?
Neumora Therapeutics Inc is not a good buy right now due to significant financial losses and a declining stock price. The current price is $1.39, and the company has reported a net loss of $43.1 million for Q2 2026, which is a concern for long-term viability. Additionally, the RSI is at 30.313, indicating the stock is oversold but may not recover soon given the negative sentiment and recent downgrades from analysts.
NMRA stock price ended at $1.39 on Friday, after losing -6.08%
Neumora Therapeutics Inc (NMRA) last closed at $1.39, losing -6.08%. These facts feed the 1-day and 1-week NMRA price prediction above.
Forecast Drivers
Neumora Therapeutics Inc (NMRA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches NMRA, ranked by similarity.
Seasonality analysis for NMRA
Historically the probability of a positive August return for NMRA is 4.76%. February offers the highest probability of a positive month at 60.34%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for NMRA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.57 | $1.77 | $1.77 | +27.07% |
| Sep 2026 | $1.92 | $2.12 | $2.53 | +52.85% |
| Oct 2026 | $2.00 | $2.20 | $2.24 | +58.16% |
| Nov 2026 | $2.23 | $2.23 | $2.41 | +60.71% |
| Dec 2026 | $1.48 | $1.81 | $1.86 | +30.16% |
In 2026, Neumora Therapeutics Inc (NMRA) is projected to range from $1.48 to $2.53.
Neumora Therapeutics Inc 2026 monthly forecast
In Aug 2026, Neumora Therapeutics Inc is projected to average $1.77, with a low of $1.57 and high of $1.77.
In Sep 2026, Neumora Therapeutics Inc is projected to average $2.12, with a low of $1.92 and high of $2.53.
In Oct 2026, Neumora Therapeutics Inc is projected to average $2.20, with a low of $2.00 and high of $2.24.
In Nov 2026, Neumora Therapeutics Inc is projected to average $2.23, with a low of $2.23 and high of $2.41.
In Dec 2026, Neumora Therapeutics Inc is projected to average $1.81, with a low of $1.48 and high of $1.86.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。